Print Article

FATF guidance on Money Laundering from Fentanyl and Synthetic Opioids


Organised crime groups are fuelling a synthetic opioid crisis that has contributed to hundreds of thousands of drug overdose deaths in the past decade.

In North America, the non-medical use of fentanyl is the main driver behind a record number of overdoses and opioid-related deaths. In parts of Africa, a tramadol epidemic is having a significant impact on public health. While across Asia, many countries report a growing number of cases.

This report looks at the way proceeds are laundered from synthetic opioid trafficking.

Organised crime groups use a range of methods, including

  • Bulk cash smuggling, cash couriers, trade-based money laundering and virtual assets (crypto),
  • As well as shell companies and the services of professional money launderers.

Even though a majority of countries identify drug trafficking as a major predicate offence for money laundering, the number of investigations and prosecutions concerning the laundering of proceeds from synthetic opioid trafficking remains low.

This report aims to raise awareness about the opioid trade, including the use of precursor chemicals, and the related global financial flows.

It also makes recommendations on the best approaches to detect and disrupt the criminal networks involved. These include:

  1. Improving risk understanding in this area, including regarding supply chains and the pharmaceutical industry's role, to develop more robust legal and regulatory frameworks to combat the trade in illicit opioids.
  2. Training prosecutors and relevant authorities to conduct financial investigations in the precursor supply chain.
  3. Identifying and leveraging existing mechanisms to expand international cooperation between source, transit and destination countries to identify and disrupt synthetic opioid supply chains.
  4. Using public-private partnerships to raise risk awareness of dark web marketplaces and virtual assets (crypto), share red flag information and help the private sector better identify and report suspicious activity.

The report includes relevant risk indicators that will help identify potential trafficking of illicit synthetic opioids.


The Team

Meet the team of industry experts behind Comsure

Find out more

Latest News

Keep up to date with the very latest news from Comsure

Find out more


View our latest imagery from our news and work

Find out more


Think we can help you and your business? Chat to us today

Get In Touch

News Disclaimer

As well as owning and publishing Comsure's copyrighted works, Comsure wishes to use the copyright-protected works of others. To do so, Comsure is applying for exemptions in the UK copyright law. There are certain very specific situations where Comsure is permitted to do so without seeking permission from the owner. These exemptions are in the copyright sections of the Copyright, Designs and Patents Act 1988 (as amended)[]. Many situations allow for Comsure to apply for exemptions. These include 1] Non-commercial research and private study, 2] Criticism, review and reporting of current events, 3] the copying of works in any medium as long as the use is to illustrate a point. 4] no posting is for commercial purposes [payment]. (for a full list of exemptions, please read here]. Concerning the exceptions, Comsure will acknowledge the work of the source author by providing a link to the source material. Comsure claims no ownership of non-Comsure content. The non-Comsure articles posted on the Comsure website are deemed important, relevant, and newsworthy to a Comsure audience (e.g. regulated financial services and professional firms [DNFSBs]). Comsure does not wish to take any credit for the publication, and the publication can be read in full in its original form if you click the articles link that always accompanies the news item. Also, Comsure does not seek any payment for highlighting these important articles. If you want any article removed, Comsure will automatically do so on a reasonable request if you email